Compare SHIM & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHIM | TKNO |
|---|---|---|
| Founded | 1990 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 138.1M |
| IPO Year | 2023 | 2021 |
| Metric | SHIM | TKNO |
|---|---|---|
| Price | $3.58 | $4.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 214.2K | 99.3K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.95 | 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $492,844,000.00 | $40,520,000.00 |
| Revenue This Year | $13.99 | $8.27 |
| Revenue Next Year | $6.94 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 2.63 | ★ 7.35 |
| 52 Week Low | $1.37 | $1.91 |
| 52 Week High | $6.76 | $6.68 |
| Indicator | SHIM | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 35.11 | 73.55 |
| Support Level | $3.35 | $4.13 |
| Resistance Level | $4.04 | $4.94 |
| Average True Range (ATR) | 0.61 | 0.32 |
| MACD | -0.19 | 0.04 |
| Stochastic Oscillator | 7.17 | 96.03 |
Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.